Daratumumab
How it works: Removing B cells →
In development for MS or related diseases. No approval for these conditions is recorded in the bank.
- Molecule type
- Antibody
- Mechanism (ChEMBL)
- Lymphocyte differentiation antigen CD38 inhibitor
- Targets
- ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1
Approvals
None recorded.
Safety communications
None recorded.
Trials
Running now
- DAWN
Running, not recruiting · Phase 2 / Phase 3 · NMOSD · ongoing
For information only, not medical advice. Talk to your neurologist before changing treatment.
Hypotheses involving this medicine
Loading hypotheses…
Loading reviews and guidelines…
Lab studies
Lab studies in animals or cells. Results in animals often do not hold in people, and these studies never change the status of an idea.
Loading lab studies…
Assembled by software from public sources and not checked by people. Each record links to its source. Report an error